Addex Therapeutics Ltd (ADXN)
8.40
-0.23
(-2.67%)
USD |
NASDAQ |
Nov 14, 11:33
Addex Therapeutics Total Return Level: 8.63 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 8.63 |
November 12, 2024 | 8.77 |
November 11, 2024 | 10.78 |
November 08, 2024 | 10.55 |
November 07, 2024 | 10.64 |
November 06, 2024 | 11.01 |
November 05, 2024 | 11.08 |
November 04, 2024 | 10.96 |
November 01, 2024 | 10.70 |
October 31, 2024 | 9.75 |
October 30, 2024 | 10.72 |
October 29, 2024 | 10.41 |
October 28, 2024 | 11.01 |
October 25, 2024 | 11.01 |
October 24, 2024 | 11.56 |
October 23, 2024 | 10.86 |
October 22, 2024 | 10.67 |
October 21, 2024 | 10.30 |
October 18, 2024 | 10.44 |
October 17, 2024 | 10.60 |
October 16, 2024 | 10.55 |
October 15, 2024 | 10.45 |
October 14, 2024 | 10.50 |
October 11, 2024 | 10.26 |
October 10, 2024 | 10.34 |
Date | Value |
---|---|
October 09, 2024 | 10.24 |
October 08, 2024 | 10.34 |
October 07, 2024 | 9.335 |
October 04, 2024 | 9.44 |
October 03, 2024 | 9.400 |
October 02, 2024 | 9.28 |
October 01, 2024 | 9.23 |
September 30, 2024 | 9.77 |
September 27, 2024 | 9.05 |
September 26, 2024 | 9.63 |
September 25, 2024 | 9.950 |
September 24, 2024 | 10.21 |
September 23, 2024 | 10.60 |
September 20, 2024 | 9.84 |
September 19, 2024 | 9.67 |
September 18, 2024 | 9.59 |
September 17, 2024 | 10.13 |
September 16, 2024 | 10.10 |
September 13, 2024 | 9.64 |
September 12, 2024 | 10.21 |
September 11, 2024 | 10.30 |
September 10, 2024 | 10.54 |
September 09, 2024 | 10.98 |
September 06, 2024 | 11.18 |
September 05, 2024 | 11.31 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
5.15
Minimum
Dec 18 2023
483.80
Maximum
Dec 24 2020
96.60
Average
38.60
Median
Jul 21 2022
Total Return Level Benchmarks
AC Immune SA | 3.135 |
CRISPR Therapeutics AG | 49.79 |
NLS Pharmaceutics Ltd | 3.49 |
Molecular Partners AG | 5.51 |
MoonLake Immunotherapeutics | 51.06 |